PaxMedica logo.jpg
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
15 mai 2024 08h30 HE | PaxMedica, Inc.
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for...
NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
09 mai 2024 09h00 HE | NeuroSigma, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program. KidsX is a global leader in pediatric digital...
Catalight Practice G
Catalight Practice Guidelines Reflect a Contemporary Research View of the Dosage Effect and Outcome Measures in Autism Care
23 avr. 2024 17h28 HE | Catalight
WALNUT CREEK, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Catalight, one of the largest behavioral health networks in the United States working to support individuals with autism and intellectual and...
SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments
04 janv. 2024 07h18 HE | SciSparc Ltd
The collaboration included six different provisional patent applications filed by Clearmind with the United States Patent and Trademark Office in February 2023 to protect the novel combinations of...
NeuroQure Logo.png
NeuroQure Acquires Patents to Detect Autism in Newborns with a Skin Sample
13 déc. 2023 09h30 HE | NeuroQure
IRVINE, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- NeuroQure, a pioneering biotech startup specializing in gene therapy for neurocognitive disorders, has reached a pivotal milestone in the...
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
13 déc. 2023 08h18 HE | SciSparc Ltd
MitoCareX Bio met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...
Lindsey Sneed
Study: Autistic Children May Need Fewer Hours of Treatment Than Previously Thought
21 nov. 2023 13h41 HE | Catalight
Walnut Creek, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Each year, tens of thousands of parents and caregivers of children with autism spectrum disorder (ASD) face vital decisions: What kind of...
NeuroQure Logo.png
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
06 nov. 2023 12h00 HE | NeuroQure
IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NeuroQure has embarked on a transformative journey aimed at revolutionizing the treatment landscape for Fragile X Syndrome and Autism Spectrum...
SciSparc Granted Patent for its Core Technology From the Australian Patent Office
24 oct. 2023 07h20 HE | SciSparc Ltd
The Company's most recent patent further solidifies its position within the cannabis sector, complementing existing grants in the U.S., Europe, and other key jurisdictions  TEL AVIV, Israel, Oct. ...
Verbal Beginnings to Open New Early Intervention Comprehensive Autism Services Center in Frederick, MD
09 août 2023 09h00 HE | Verbal Beginnings
FREDERICK, Md., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Verbal Beginnings, a leading provider of comprehensive Autism services is thrilled to announce the opening of a new location in Frederick, Maryland,...